Donovan J P, Schafer D F, Shaw B W, Sorrell M F
Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198-3285, USA.
Lancet. 1998 Mar 7;351(9104):719-21. doi: 10.1016/S0140-6736(97)07373-X.
Cerebral oedema is a cause of morbidity and mortality in fulminant hepatic failure but has not been well documented as a complication of chronic liver diseases. We report here the development of cerebral oedema and increased intracranial pressure in 12 patients with chronic liver disease.
Between July 1, 1987, and Dec 31, 1993, we studied 12 patients aged 29-67 years with end-stage chronic liver disease. All the patients had cirrhosis, portal hypertension, hypoprothrombinaemia, hepatic encephalopathy, and decreased serum concentrations of albumin (<25 g/L). During the study, the patients developed signs of increased intracranial pressure and had documented intracranial hypertension, cerebral oedema, or both. Intracranial hypertension was suspected on physical examination and confirmed by epidural catheters. We detected cerebral oedema by computed axial tomography of the head and necropsy of the brain when possible.
All the patients had intracranial hypertension and cerebral oedema. Two patients had successful treatment of cerebral hypertension with improvement of intracranial pressure such that orthotopic liver transplantation was undertaken. Both patients became neurologically normal after transplantation. Eight patients had only a transient response to treatment and died of cerebral oedema before a transplant could be done.
Cerebral oedema and increased intracranial pressure can occur in chronic liver disease and presents as neurological deterioration. Treatment guided by monitoring of intracranial pressure can lead to the reversal of intracranial hypertension, but in most patients cerebral oedema contributes to death or places them at too high a risk for liver transplantation.
脑水肿是暴发性肝衰竭发病和死亡的一个原因,但作为慢性肝病的并发症却尚无充分记录。我们在此报告12例慢性肝病患者脑水肿及颅内压升高的情况。
在1987年7月1日至1993年12月31日期间,我们研究了12例年龄在29至67岁之间的终末期慢性肝病患者。所有患者均有肝硬化、门静脉高压、低凝血酶原血症、肝性脑病以及血清白蛋白浓度降低(<25 g/L)。在研究过程中,患者出现颅内压升高的体征,并有颅内高压、脑水肿或两者并存的记录。通过体格检查怀疑有颅内高压,并经硬膜外导管确认。我们尽可能通过头颅计算机断层扫描和脑尸检来检测脑水肿。
所有患者均有颅内高压和脑水肿。2例患者成功治疗了脑高压,颅内压得到改善,从而进行了原位肝移植。这2例患者移植后神经功能均恢复正常。8例患者对治疗仅有短暂反应,在能够进行移植之前死于脑水肿。
脑水肿和颅内压升高可发生于慢性肝病,并表现为神经功能恶化。通过监测颅内压进行指导治疗可使颅内高压逆转,但在大多数患者中,脑水肿导致死亡或使其肝移植风险过高。